---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-24-000455"
form_type: "8-K"
ticker: null
cik: "0001039466"
company_name: "NovAccess Global Inc."
filed_at: "2024-05-03T23:59:59+00:00"
generated_at: "2026-06-02T22:49:25.941492+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# NovAccess enters $26.5K note with AJB Capital and licenses IDH1 biomarker from Cedars-Sinai

## Summary
- Issued $26,500 promissory note to AJB Capital Investments, 12% interest, 10% OID, due Oct 26, 2024.
- Issued 2.5M unregistered common shares as commitment fee; granted security interest in all assets including StemVax equity.
- Default triggers 18% interest, conversion at discount, and 2x principal penalty.
- Obtained exclusive IDH1 biomarker license from Cedars-Sinai for predicting vaccine response in glioblastoma.
- Intends to use IDH1 as companion diagnostic for TLR-AD1, an FDA Orphan Drug designated candidate for CNS cancers.

## SEC filing metadata
- accession: 0001185185-24-000455
- form_type: 8-K
- cik: 0001039466
- company_name: NovAccess Global Inc.
- filed_at: 2024-05-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1039466/000118518524000455/0001185185-24-000455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1039466/000118518524000455/novaccess20240501_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-24-000455
- JSON: https://secwatch.observer/filing/0001185185-24-000455.json
- Plain text: https://secwatch.observer/filing/0001185185-24-000455.txt

## Key facts
- Debt Financings
  NovAccess Global Inc. incurred convertible notes of $26,500 with AJB Capital Investments, LLC at 12% a year maturing October 26, 2024.
  - Instrument: convertible notes
  - Principal: $26,500
  - Counterparty: AJB Capital Investments, LLC
  - Rate: 12% a year
  - Maturity: October 26, 2024
  - Event: incurrence
  source text: On April 29, 2024, NovAccess Global Inc. (“NovAccess” or the “company”) entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of $26,500 (the “note”) to AJB pursuant to the SPA.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1039466/000118518524000455/0001185185-24-000455-index.htm
- Material Agreements
  NovAccess Global Inc. entered into securities purchase agreement with AJB Capital Investments, LLC (effective 2024-04-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: AJB Capital Investments, LLC
  - Effective: 2024-04-29
  source text: On April 29, 2024, NovAccess Global Inc. (“NovAccess” or the “company”) entered into a securities purchase agreement (the “SPA”) with AJB Capital Investments, LLC (“AJB”) and issued a promissory note in the principal amount of $26,500 (the “note”) to AJB pursuant to the SPA.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1039466/000118518524000455/0001185185-24-000455-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.